PERsonalized Mammographic Screening in Norway

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age50-71
SponsorNorwegian Institute of Public Health

About this trial

The aim of this study is to assess attendance among women invited to additional breast imaging because they were identified as having an increased risk of breast cancer at screening. High-risk women were defined in two studies: Study A; women with high mammographic density, representing approximately 3-5% of screened women, and Study B; women with a false-positive screening result. Women in Study A will be offered an additional screening examination with digital breast tomosynthesis immediately within 6 months after the screening examination. Women in Study B will be offered an additional standard digital mammography examination one year after their initial screening.

Eligibility criteria

Qualifiers

invited to screening

extremely dense breast (Study A) or a false positive screening result (Study B)

Disqualifiers

Opted out or not signed written consent related to the study

Women who have opted out from giving us permission to use screening data for quality assurance and research

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

3,000 Participants
are grouped into 1 trial group

Locations

This trial has no locations

Sponsors and collaborators

Norwegian Institute of Public Health

Lead sponsor

Norwegian Cancer Society

Collaborator

University Hospital, Akershus

Collaborator

Oslo University Hospital

Collaborator

Vestre Viken Hospital Trust

Collaborator